AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Advancements in Clinical Trials for Various Cancers with Promising Results
The chapter delves into a study showcasing enhanced response rates and longer survival times compared to past data. It highlights the Phase 1B/2 study results on 68 patients, prompting the start of a first-line study for RAS-mutated MCRC. Additionally, it discusses the advancements in the Phase 2A accent trial investigating a FAK inhibitor combined with standard chemotherapy for advanced pancreatic cancer patients.